|
Activists
Prep For Legislative Session |
|||
Marijuana Super PAC Anticipates Repeat Of
Last Year Expecting
another assault on the Oregon Medical Marijuana Program as well as seriously
wanting some needed improvements, Activists and others dedicated to the Program
are gearing up for the upcoming legislative session in the Beaver state. In 2011
there were some 40+ bills and measures introduced after the word was no
cannabis related items would be done for various reasons. If only half as bad this tiem thru will
still be an effort equal to if not more than last time when the medical
cannabis community was pressed to fill up phone message machines, e-mail
boxes and hearing rooms – when we could catch up with the shell game they
sometimes play. One
action item is the Marijuana Super PAC meetings where ideas, strategies and
resources will be discussed and networked.
The first such is happening in Eugene and more are expected to be
organized around the state by various groups and individuals supporting the
concept. Agenda
items for this ongoing discussion and activity – which will utilize online
and offline tools <continued
on page 3 > |
U. S. Federal Government Continues Crackdown
On Medical Cannabis Providers
"[We] have ... advised those places where
they're trying to regulate marijuana -- which is illegal under the Control
Substances Act -- (that) they cannot do that," ONDCP Director Says Washington, DC, USA: The federal government is continuing to
target facilities that dispense cannabis to state-qualified patients, even in
cases where such facilities are properly licensed by the state. <continued
on page 3 > ___________________________________________ Non-Psychotropic Cannabinoid Inhibits Colon
Cancer Cell Proliferation
Naples, Italy: The administration of the non-psychotropic cannabis
plant constituent cannabidiol
(CBD) is protective in an experimental model of colon cancer, according to
preclinical trial data published online in the Journal of Molecular
Medicine. <continued
on page 4 > |
Wider Use Of Cannabis Therapy Could Reduce
Prescription Pain Drug Deaths
"Physicians who treat neuropathic pain with
opioids should evaluate their patients for a trial of cannabis and prescribe
it when appropriate prior to using opioids" Sacramento, CA, USA: Physicians who prescribe opioid drugs to
patients with neuropathy (nerve pain) ought to consider recommending cannabis
as <continued
on page 4 > _______________________________ Marijuana Use Not Associated With Residual
Cognitive Decline Later In Life
London, United Kingdom: Cannabis use does not appear to have residual adverse effects of
cognition or memory, according to trial data published last week in the American Journal of
Epidemiology. <continued
on page 5 > |
|
|
* Volume 9, Issue 1 * January * 2012
* www.MercyCenters.org *
|
||
* The MERCY News * |
|
_____________________ The MERCY News Report is an
all-volunteer, not-for-profit project to record and broadcast news,
announcements and information about medical cannabis in Oregon, across
America and around the World. For more information about the MERCY News, contact us. Via
Snail Mail: The MERCY
News 1469 Capital
St. NE, Suite 100, Salem, Ore.,
97301 503.363-4588 E-mail: Mercy_Salem@hotmail.com Or
our WWW page: www.MercyCenters.org Check it
out! ___________________________ MERCY On The Tube! in Salem,
Oregon area thru Capital Community Television, Channel 23.
Call In – 503.588-6444 - on Friday at 7pm, or See us on Wednesdays
at 06:30pm, Thursdays at 07:00pm, Fridays at 10:30pm and Saturdays at
06:00pm. Visit – http://mercycenters.org/tv/ |
About
MERCY – The Medical Cannabis Resource Center MERCY is a non-profit, grass roots organization
founded by patients, their friends and family and other compassionate and
concerned citizens in the area and is dedicated to helping and advocating for
those involved with the Oregon Medical Marijuana Program (OMMP). MERCY is based in the
Salem, Oregon area and staffed on a volunteer basis. The
purpose is to get medicine to patients in the short-term while working with
them to establish their own independent sources. To
this end we provide, among other things, ongoing education to people and
groups organizing clinics and other Patient Resources, individual physicians
and other healthcare providers about the OMMP, cannabis as medicine and
doctor rights in general. The mission of the organization
is to help people and change the laws. We advocate reasonable, fair and effective
marijuana laws and policies, and strive to educate, register and empower
voters to implement such policies. Our philosophy is one of teaching
people to fish, rather than being dependent upon others. Want to get your Card? Need Medicine Now? Welcome to The Club! MERCY – the Medical Cannabis Resource Center
hosts Mercy Club Meetings every Wednesday at - 1469 Capital
Street NE, Suite #100, Salem, 97301 – from 7pm to 9pm to
help folks get their card, network patients to medicine, assist in finding a
grower or getting to grow themselves, or ways and means to medicate along
other info and resources depending on the issue. visit – www.MercyCenters.org
- or Call 503.363-4588 for more. The Doctor is In ... Salem! * MERCY is Educating Doctors on signing for their
Patients; Referring people to Medical Cannabis Consultations when their
regular care physician won't sign for them; and listing all Clinics around
the state in order to help folks Qualify for the OMMP and otherwise Get their
Cards. For our Referral Doc in Salem,
get your records to – 1469 Capital Street NE, Suite
#100, Salem, 97301, NOTE: There is a $25 non-refundable deposit
required. Transportation and Delivery
Services available for those in need.
For our Physician Packet to educate your Doctor, or a List of Clinics
around the state, visit – www.MercyCenters.org
- or Call 503.363-4588 for more. Other Medical Cannabis Resource NetWork
Opportunities for Patients as well as CardHolders-to-be. * whether Social meeting, Open to public
–or- Cardholders Only * visit: http://mercycenters.org/events/Meets.html ! Also Forums - a means to
communicate and network on medical cannabis in Portland across Oregon and
around the world. A list of
Forums, Chat Rooms, Bulletin Boards and other Online Resources for the
Medical Cannabis Patient, CareGiver, Family Member, Patient-to-Be and Other
Interested Parties. * Resources > Patients (plus) > Online
> Forums * Know any? Let everybody else know!
Visit: http://mercycenters.org/orgs/Forums.html and Post It! |
2 mercycenter@hotmail.com * |
Volume 9, Issue 1 *
January * 2012 |
|
||
|
<continued from MARIJUANA SUPER PAC, page 1
> to
enable folks to be involved remotely and on their own schedule – will include
such things as: Ø
Local Bills and Candidates, both HomeGrown
and Viable Mainstream. ·
Initiative 09 >
Oregon Cannabis Tax Act (OCTA) >> Allows personal marijuana, hemp
cultivation/use without license; establishes Commission to regulate
commercial marijuana cultivation/sale. ·
Initiative 24 > Oregon
Marijuana Policy Intiative (OMPI) >> amends Oregon Constitution, allowing use, possession and production of
marijuana by adults (21 and older). ·
Petition to Initiative
by Sensible Oregon; Removes criminal and civil penalties, for adults 21 and
over, for possession, cultivation, and use of marijuana; retains penalties
for minors. ·
… and more local ideas
and activities! Ø
Federal Bills and Candidates, Ø
Other States – what can we learn, how can we
help. Ø
Other Countries – same. … just to name a few. What’s yours? Visit - http://willamettevalleynorml.org/action/MJSP.html - or Contact MJSP organizer Dan Koozer at (541) 517-0957 for more info and to arrange yours.
_____________________________________________________________ <continued from U. S. FEDERAL GOVERNMENT CONTINUES CRACKDOWN ON
MEDICAL CANNABIS PROVIDERS, page 1 > On Thursday, federal authorities sent
letters to multiple Colorado dispensaries stating that "action will
be taken to seize and forfeit their property" if they do not cease
operations within 45 days. The letters, sent by US Attorney John Walsh, state:
"This ... constitutes formal notice that action will be taken to seize
and forfeit (your) property if you do not cause the sale and/or distribution
of marijuana and marijuana-infused substances at (this) location to be
discontinued. ... [T]he Department of Justice |
has the authority to enforce federal law even when
such activities may be permitted under state law. "The
Justice Department alleges that all of the facilities cited in their
complaint are in violation of 21
USC Code Sec. 860, which prohibits the distribution of a federally
controlled substance within one thousand feet of "a public or private
elementary, vocational, or secondary school or a public or private college,
junior college, or university, or a playground, or housing facility owned by
a public housing authority." Colorado state law imposes similar zoning
restrictions; however, many if not all of the facilities in question are
believed to have been grandfathered in under the law and were operating with a
valid state license. While the federal government in recent months has
utilized similar
tactics to close down cannabis providers in California and has also
coordinated DEA-led raids of dispensaries in other states, most notably in Washington
and Montana, last week's efforts in Colorado mark the first time that the
federal authorities have targeted facilities that are operating explicitly
under a state license. Speaking on Tuesday with KQED News in San Francisco,
Tommy LaNier -- Director of the White House Office of National Drug Control
Policy's National Marijuana Initiative -- warned that Justice Department
officials are also intending to target city and county officials who oversee
local regulations permitting the production or dispensing of medical cannabis.
"[We] have ... advised those places where they're trying to regulate
marijuana -- which is illegal under the Control Substances Act -- (that) they
cannot do that," LaNier said. He added that the Justice Department's crackdown
intends to eventually target every state that allows for some form of limited
legalization of marijuana for medical purposes. In December, US Attorney General Eric Holder told members of Congress that the Justice Department
would only target medical <continued
on next page> |
|
|
503.363-4588 * www.MercyCenters.org 3 |
||
* The MERCY News * |
|
||
|
<continued
from previous page> cannabis operators that "use marijuana
in a way that's not consistent with the state statute." Members of the NORML
Legal Committee filed suit in November against the federal government
arguing that its actions were in violation of the Ninth, Tenth, and
Fourteenth Amendments of the US Constitution. That lawsuit remains
pending. For more information,
please contact Keith Stroup, NORML Legal Counsel, or Allen St. Pierre, NORML
Executive Director, at (202) 483-5500. _____________________________________________________________ <continued from WIDER USE OF CANNABIS THERAPY COULD REDUCE
PRESCRIPTION PAIN DRUG DEATHS, page 1 > an alternative therapy, according to a
peer-reviewed paper published online this week in the Harm
Reduction Journal. "There
is sufficient evidence of safety and efficacy for the use of
(cannabis/cannabinoids) in the treatment of nerve pain relative to
opioids," the commentary states. "In states where medicinal
cannabis is legal, physicians who treat neuropathic pain with opioids should
evaluate their patients for a trial of cannabis and prescribe it when
appropriate prior to using opioids. ... Prescribing cannabis in place of
opioids for neuropathic pain may reduce the morbidity and mortality rates
associated with prescription pain medications and may be an effective harm
reduction strategy." The author notes that between the years 1999
and 2006, "approximately 65,000 people died from opioid analgesic
overdose." By contrast, he writes "[N]o one has ever died from an
overdose of cannabis." In clinical trials,
inhaled cannabis has consistently been shown to reduce
neuropathic pain of diverse causes in subjects unresponsive to standard pain
therapies. In November, clinical investigators at the
University of California, San Francisco reported that vaporized cannabis augments
the analgesic effects of opiates in subjects prescribed morphine or
oxycodone. Authors of the study surmised that cannabis-specific interventions
|
"may allow for opioid treatment at lower doses with
fewer [patient] side effects." Neuropathy affects between five percent and 10
percent of the US population. The condition is often unresponsive to
conventional analgesic medications such as opiates and non-steroidal
anti-inflammatory drugs. For more
information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org.
Full text of the paper, "Prescribing cannabis for harm reduction"
is available online at: http://www.harmreductionjournal.com/content/pdf/1477-7517-9-1.pdf. _____________________________________________________________ <continued from NON-PSYCHOTROPIC CANNABINOID INHIBITS COLON CANCER
CELL PROLIFERATION, page 1 > Investigators at the
University of Naples assessed the effect of CBD on colon carcinogenesis in
mice. Researchers reported that CBD administration was associated with
cancerous tumor reduction and reduced cell proliferation. Authors wrote: "Although cannabidiol
has been shown to kill
glioma cells, to inhibit cancer cell invasion and to reduce
the growth of breast carcinoma and lung metastases in rodents, its effect
on colon carcinogenesis has not been evaluated to date. This is an important
omission, since colon cancer affects millions of individuals in Western
countries. In the present study, we have shown that cannabidiol exerts (1)
protective effects in an experimental model of colon cancer and (2)
antiproliferative actions in colorectal carcinoma cells." Authors also acknowledged that CBD possesses
"an extremely safe profile in humans." They concluded, "[O]ur
findings suggest that cannabidiol might be worthy of clinical consideration
in colon cancer prevention." Clinical
review data published in the scientific journal Current Drug Safety
in December concluded that CBD is "non-toxic" to healthy cells and
is "well tolerated" in humans. Nevertheless, cannabidiol is
presently classified under federal law as a schedule I prohibited substance. Such substances are
required by law to possess "a high potential for abuse," "a <continued
on next page> |
|
4 mercycenter@hotmail.com * |
|
||
Volume 9, Issue 1 *
January * 2012 |
|
||
|
<continued
from previous page> lack of accepted safety ... under medical
supervision," and "no currently accepted medical use in treatment
in the United States." Separate
preclinical trials evaluating the anti-cancer activities of cannabinoids
and endocannabinoids show that their administration can inhibit the
proliferation of a variety of cancerous cell lines, including breast
carcinoma, prostate carcinoma, gastric adenocarcinoma, skin carcinoma,
leukemia cells, neuroblastoma, lung carcinoma, uterus carcinoma, thyroid
epithelioma, pancreatic adenocarcinoma, cervical carcinoma, oral cancer,
biliary tract cancer (cholangiocarcinoma), and lymphoma. For more information, please contact Paul
Armentano, NORML Deputy Director, at: paul@norml.org. Full text of
the study, "Chemopreventive effect of the non-psychotropic
phytocannabinoid cannabidiol on experimental colon cancer," appears in
the Journal of Molecular Medicine. A separate summary of the anti-cancer
properties of cannabinoids is available from NORML here: http://norml.org/library/item/gliomascancer. _____________________________________________________________ <continued from MARIJUANA USE NOT ASSOCIATED WITH RESIDUAL COGNITIVE
DECLINE LATER IN LIFE, page 1 > Researchers at the Kings College, School of
Medicine in London investigated the prospective association between
self-reported illicit drug use and cognitive functioning during the mid-adult
years. A total of 8,992 participants who were surveyed at 42 years of age in
the National Child Development Study (1999-2000) were included in the study. Authors analyzed data on three cognitive functioning
measures (memory index, executive functioning index, and overall cognitive
index) when the participants were 50 years of age (2008-2009). Multivariable
regression analyses were performed to estimate the association between
different illicit drug use measures at 42 years of age and cognitive
functioning at 50 years of age. Investigators reported that those subjects who had
used illegal drugs, primarily cannabis, as recently as in their 40s performed
as well or |
slightly better on the tests than did their peers
who had never used illicit substances. The scientists concluded, "At the population
level, it does not appear that current illicit drug use is associated with
impaired cognitive functioning in early middle age. ... The lack of
association between current illegal drug use and cognitive functioning also
appears to be congruent with previous evidence showing the absence of a
long-term residual effect of illicit drug use on cognition." For more information, please contact Paul
Armentano, NORML Deputy Director, at: paul@norml.org. Full text of
the study, "Is illicit drug use harmful to cognitive functioning in the
mid-adult years? A cohort-based investigation," appears in the American
Journal of Epidemiology. Additional information regarding cannabis use and
cognitive function is available online from NORML at: http://norml.org/component/zoo/category/cannabis-and-the-brain-a-user-s-guide _____________________________________________________________ JAMA: Long-Term Exposure To Cannabis Smoke
Not Associated With Adverse Effects On Pulmonary Function
"Our findings suggest that occasional use of
marijuana ... may not be associated with adverse consequences on pulmonary
function." San
Francisco, CA, USA:
Exposure to moderate levels of cannabis smoke, even over the long-term, is not associated with adverse effects on pulmonary
function, according to clinical trial data
published Tuesday in the Journal of the American Medical Association
(JAMA). Investigators at the University of California, San
Francisco analyzed the association between marijuana exposure and pulmonary <continued
on next page> |
|
|
503.363-4588 * www.MercyCenters.org 5 |
||
* The MERCY News * |
|
||
|
<continued
from previous page> function over a 20-year period in a cohort
of 5,115 men and women in four US cities. Predictably, researchers "confirmed the
expected reductions in FEV1 (forced expiratory volume in the first second of
expiration) and FVC (forced vital capacity)" in tobacco smokers. By
contrast, "Marijuana use was associated with higher FEV1 and FVC at the
low levels of exposure typical for most marijuana
users. With up to 7 joint-years of lifetime exposure (e.g., 1 joint/d for 7
years or 1 joint/wk for 49 years), we found no evidence that increasing
exposure to marijuana adversely affects pulmonary function." They
conclude, "Our findings suggest that occasional use of marijuana ... may
not be associated with adverse consequences on pulmonary function." The
study's results are consistent with previous findings reporting no
significant decrease in pulmonary function associated with moderate cannabis
smoke exposure. According to a 2007 literature review
conducted by researchers at the Yale University School of Medicine and
published in the Archives of Internal Medicine, cannabis smoke
exposure is not associated with airflow obstruction (emphysema), as measured
by airway hyperreactivity, forced expiratory volume, or other measures. In 2006,
the results
of the largest case-controlled study ever to investigate the respiratory
effects of marijuana smoking reported that cannabis use was not associated
with lung-related cancers, even among subjects who reported smoking more than
22,000 joints over their lifetime. "We
hypothesized that there would be a positive association between marijuana use
and lung cancer, and that the association would be more positive with heavier
use," the study's lead researcher, Dr. Donald Tashkin of the University of California at Los
Angeles stated. What we found instead was no association at all,
and even a suggestion of some protective effect" among marijuana smokers
who had lower incidences of cancer compared to non-users. Separate studies of
cannabis smoke and pulmonary function have indicated that chronic exposure
may be associated with an increased
risk of certain respiratory complications, including cough, bronchitis,
phlegm. However, the ingestion of
cannabis via alternative methods such as edibles, liquid tinctures, or via vaporization -- a process
whereby the plant's cannabinoids are heated to the |
point of vaporization but below the point of combustion -- virtually eliminates consumers'exposure to such unwanted risk
factors and has been determined
to be a 'safe and effective' method of ingestion in clinical trial
settings. For more information, please contact Allen St. Pierre, NORML
Executive Director, at (202) 483-5500, or Paul Armentano, NORML Deputy
Director, at: paul@norml.org. Full text of the study, "Association
between marijuana exposure and pulmonary function over 20 years,"
appears in the Journal of the American Medical Association. _____________________________________________________________ California: Attorney General Asks State's
Lawmakers To Clarify Issues Concerning Dispensing Of Medical Cannabis
Sacramento,
CA, USA: California Attorney General Kamala Harris
is requesting lawmakers to "clarify" the state's
guidelines regarding the production and distribution of marijuana for medical
purposes. In a December 21, 2011 letter
from Harris to Assembly Speaker John A. Perez and Senate President Pro-Tempore
Darrell Steinberg, the Attorney General states, "[S]tate law ... needs
to be reformed, simplified, and improved to better explain to patients and
law enforcement alike how, when, and where individuals may cultivate and
obtain physician-recommended marijuana." Specifically,
Harris is asking lawmakers to "articulate the scope" of patients'
rights to cultivate cannabis in a "collective" manner. Harris
further requests that legislators provide regulations regarding the operation
of cannabis dispensaries, stating, "Here the legislature could weigh in
with rules about hours, locations, audits, security, employee background
checks, zoning, compensation .... (and) what it means for a collective or a
cooperative to operate as a 'non-profit.'" The Attorney General also
requests that lawmakers address issues regarding the production and
distribution of cannabis-infused food products, which she states are not
specifically regulated under existing state law. Harris'
letter follows a statewide crackdown
of California medical cannabis producers and providers by the United States
Justice Department. Neither the language of
Proposition 215, enacted by voters in 1996, nor the Medical Marijuana Program
Act, enacted by the legislature in 2003, explicitly addresses the act of
cannabis distribution by third- party
dispensaries. In 2008, then-Attorney General (now California Governor) Jerry
Brown issued <continued
on next page> |
|
6 mercycenter@hotmail.com * |
|
||
Volume 9, Issue 1 *
January * 2012 |
|
||
|
<continued
from previous page> guidelines stating that such facilities should operate on
a non-profit basis, "acquire marijuana only from their constituent
members," and "may not distribute medical marijuana to any person
who is not a member in good standing of the organization." Harris' letter references the 2008 guidelines, but states "[T]he
facts today are far more complicated" than they were then and
acknowledges that "non-binding guidelines will not solve (California's)
problems." For more
information, please contact Allen St. Pierre, NORML Executive Director, at
(202) 483-5500 or visit California NORML at: http://www.canorml.org _____________________________________________________________ Maryland Considering
Comprehensive Medical Cannabis Bill;
House Bill Would Replace Last Year’s Temporary Measure
A comprehensive medical cannabis
bill was introduced in Maryland’s House of Delegates this month. House Bill
15, introduced by Delegate Cheryl Glenn (D-Baltimore) would replace a bill
passed last year as a stop-gap measure while a state-appointed workgroup
studied the issue. The Maryland Medical Marijuana
Act would establish a strictly regulated production and distribution system
with clear rules for qualified patients and law enforcement. HB 15, developed
with input from ASA, would also shield patients from housing and workplace
discrimination. Maryland’s existing law, passed
by the legislature last year, has limited protections
for patients but does not address how patients could legally obtain medical
cannabis, nor does it protect patients from arrest and prosecution. The 18-member "workgroup" the legislature
created when it passed the law has issued two legislative proposals,
supported by an almost equal number of workgroup members. One
proposal, backed by workgroup chair Maryland Health & Mental Hygiene Secretary Dr.
Joshua Sharfstein, would create a unique distribution system through
"Academic Medical Centers." Similar state-run arrangements, such as
New Mexico’s attempt to create a distribution program staffed by |
state employees, have faced
aggressive federal legal challenge. The other proposal, backed by Maryland
Del. Dr. Dan Morhaim (D-Baltimore County), mirrors a bill that failed to pass
out of committee last year because of objections from Secretary Sharfstein
and a fiscal note that alleged exorbitant costs to Maryland taxpayers "As a legislator dedicated
to addressing the needs of medical marijuana patients in Maryland, I am very
disappointed in both legislative proposals being offered by the commissioned
workgroup," said Del. Glenn. "I am offering a different bill --
what I believe is a common-sense approach to this issue, taking into account
not only the needs of medical marijuana patients, but also the needs of the
larger communities in which they live.
One of the key differences between Del. Glenn's bill and the workgroup
proposals is that HB15 would allow patients to produce their own medicine,
while the other proposals would not. "In places that have
ignored the need for patients to cultivate their own medical marijuana --
such as Delaware, New Jersey, and the District of Columbia -- thousands of
patients have been forced to go without," said Del. Glenn. "This is
unacceptable and should be a lesson we learn from, not one we repeat in
Maryland. HB 15 will first be heard by the
Health and Government Operations & Judiciary Committees. If passed, HB 15
will take effect on June 1st and require the Department of Health and Mental
Hygiene to adopt regulations on or before September 1st of this year. Further information: HB
308 _____________________________________________________________ ASA Files Federal Appeal in
Bid
|
|
|
503.363-4588 * www.MercyCenters.org 7 |
||
|
|
||
|
<continued from ASA FILES FEDERAL APPEAL IN BID Since
1970, two other rescheduling petitions have sought to restore cannabis to the
list of recognized medicines, but the medical record was reviewed only once
by the courts in 1994. Since then thousands of peer reviewed articles have
been published on research exploring the medical applications and potential
of cannabis and the cannabinoids that are its constituent chemicals. ASA
argues that the federal government acted arbitrarily and capriciously in
ignoring medical research and practice, with the result that legal access to
cannabis is being denied to the millions of patients throughout the United
States who may benefit from it. The
DEA was only able to deny the therapeutic value of cannabis by applying
different evaluative criteria to cannabis than other drugs, misrepresenting
social science research, and relying on unsubstantiated assumptions,
according to ASA’s brief. ASA
is urging the court to "require the DEA to analyze the scientific data
evenhandedly," and order "a hearing and findings based on the
scientific record." That record was even more conclusive in 2002 than it
was in 1988 when the DEA’s Chief Administrative Law Judge reviewed it and
ruled that denying medical access was “unreasonable, arbitrary and
capricious.” Since the CRC petition was originally filed, considerably more
peer-reviewed research has been published that shows the benefits of cannabis
for treating a variety of serious conditions, and its therapeutic value has
been more widely acknowledged. For instance, the National Cancer Institute, a
division of the federal Department of Health and Human Services, has added
cannabis to its list of Complementary Alternative Medicines, noting that it
has been used therapeutically for millennia. ASA
argues in its appeal that the additional scientific evidence of the last
decade is relevant and must be considered. |
The
original petition on behalf the CRC was filed by attorneys David Holland and
Michael Kennedy. The CRC is comprised of several individual patients and
advocacy groups, including Patients Out of Time and ASA. Contact: Americans for Safe Access (ASA),
1322 Webster St., Ste. 402, Oakland, CA 94612 * Phone: 510-251-1856 * Fax:
510-251-2036 * or visit – http://www.AmericansForSafeAccess.org More information: _____________________________________________________________ ACTION ALERT: Medical Cannabis
Week – February 13-17
Medical Cannabis Week is the
best time of the year to action! Rally for safe access on Thursday,
Feb. 16! Patients and advocates will be holding rallies in cities
throughout the country to tell President Obama that it’s time to stop the
interference with state programs and reclassify cannabis as a medicine. Here are some other ways you
can get involved: Monday, Feb 13: Call
the White House at 202-456-1111 and tell Pres. Obama to keep his promise to
not use Justice Department resources to undermine state laws, stop putting
politics before science, and act immediately to reclassify cannabis as
medicine. Tuesday, Feb 14:
Contact Congress, 202-224-3121, and urge your representative to sponsor
legislation to reclassify cannabis, end federal interference in state
programs, and provide licensed patients and provides a defense in court. Wednesday, Feb 15: Ask
your Governor to sign the DEA Rescheduling Petition. Find your Governor’s
contact information at www.usa.gov/Contact/Governors.shtml Thursday, Feb 16:
Rally for Safe Access! Find a rally near you! Rally locations can be found at
AmericansForSafeAccess.org/MMW. Friday, Feb 17: Join
the movement and help fund the fight for safe access. Find out how at AmericansForSafeAccess.org/join. |
|
|
* The MERCY News
>
mercycenter@hotmail.com > (503)
363-4588 <
www.MercyCenters.org * |
||